The Carrell-Krusen Abstract Selection Committee invites you to submit an abstract for presentation at the 42nd Annual Carrell-Krusen Neuromuscular Symposium, to be held February 20-21, 2020 in Dallas, Texas.



General Guidelines

  • Use UPPER CASE FONT for the title of the project
  • Indicate possible conflicts of interest with industry
  • Spell out all abbreviated terms at first use
  • Do not include a continuation page, illustrations, or tables
  • Cases will be discussed with the goal of identifying the diagnosis during the live presentation, as part of the learning activity. As such, the final diagnosis is to be omitted from the title and body of the abstract.
  • Do NOT exceed 300 words or use continuation pages, illustrations or tables. Please omit the diagnosis from the title and the body of the abstract.


  • Content addresses the identification, diagnosis, treatment and/or management of neuromuscular diseases.
  • Abstracts must report work not presented or published prior to the meeting
  • All authors must be listed in space provided (please include a good email address)
  • Please see table below for presentation category, format and abstract submission content details

Abstract Category

Presentation Format

Abstract Content

Live/Video Patient

40 minute podium presentation

Concise summary of history and physical exam, video demonstrating physical/neurologic findings, lab results, discussion of differential diagnosis and final diagnosis with management/treatment

Scientific/Case Series

10 minute podium presentation

Include purpose of study, methods, results and conclusions


10 minute podium presentation

Include brief clinical history/PE, results of electrodiagnostic and histologic studies, DNA analysis and conclusions.


Printed Poster (NOT certified for CME)

Include purpose of study, methods, results and conclusions

Please note that the Abstract Selection Committee may change the Abstract category based on the context of submissions, format options available in the schedule and overall goals of the conference. You will be notified of this change upon acceptance of submission.


Selection Criteria:

The abstract selection committee is committed to a rigorous, systematic process to identify presentations that will contribute to the overall goals of the symposium. As such, the evaluation and selection of abstracts will be based on:

  • Clarity of purpose/problem statement
  • Quality of research methods (if applicable)
  • Relevance to medical practice (applicability or advances knowledge in the field)


  • The First Author of accepted abstracts will be notified by December 20, 2019.
  • The time allowed for presentations from the platform and posters may vary according to the material presented and the needs of the session and will be determined at time of abstract acceptance.
  • Accepted abstracts will be printed in the Journal of Clinical Neuromuscular Disease.

A panel from the Abstract Selection Committee Awards will identify the best abstract presentations, which will be announced prior to the close of the symposium


  • It is the policy of ACCME that all persons in the position to control the content of an educational activity are required to disclose all relevant financial relationships in any amount occurring within the past 12 months with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients. A primary mechanism to resolve identified conflicts of interest is a content review that is prior to the activity.
  • Upon acceptance of the abstract, ALL authors will be emailed a link to complete an online Conflict of Interest Disclosure form.
  • All online disclosure forms must be completed no later than Friday, January 3, 2020. It is the responsibility of the First Author to ensure all disclosures are submitted by this deadline. Failure to provide this information may result in your abstract being removed from the program.


  • It is the speakers’ responsibility to register for the symposium. Abstract acceptance does not guarantee any type of registration discount.